Showing results (491-500 of 540) with videos related to
Sort By:
Pageof 54
International Journal of Molecular Sciences|August 15, 2018
Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in PreeclampsiaOlga V Fedorova, Valentina V Ishkaraeva, Yulia N Grigorova, et al.Journal of the American Heart Association|October 4, 2016
Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic SignalingSteven T Haller, Yanling Yan, Christopher A Drummond, et al.Journal of Virology|December 21, 2018
Solution Structure, Self-Assembly, and Membrane Interactions of the Matrix Protein from Newcastle Disease Virus at Neutral and Acidic pHE V Shtykova, M V Petoukhov, L A Dadinova, et al.Molecular Cell|February 18, 2018
Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory SignalingTatiana Goncharov, Stefanie Hedayati, Melinda M Mulvihill, et al.Plos One|June 1, 2019
Surface characterization of the thermal remodeling helical plant virusAlexander L Ksenofontov, Natalia V Fedorova, Gennady A Badun, et al.Platelets|December 21, 2019
Platelet function and blood coagulation system status in childhood essential thrombocythemiaDmitrii M Polokhov, Nikolay M Ershov, Anastasia A Ignatova, et al.Plos One|December 21, 2013
Structural analysis of influenza A virus matrix protein M1 and its self-assemblies at low pHEleonora V Shtykova, Lyudmila A Baratova, Natalia V Fedorova, et al.International Journal of Clinical Oncology|November 26, 2021
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphomaLiudmila V Fedorova, Kirill V Lepik, Nikita P Volkov, et al.Hypertension (Dallas, Tex. : 1979)|February 1, 2006
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathyDavid J Kennedy, Sandeep Vetteth, Sankaridrug M Periyasamy, et al.Hypertension (Dallas, Tex. : 1979)|November 4, 2009
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufageninJiang Tian, Amjad Shidyak, Sankaridrug M Periyasamy, et al.Pageof 54